"It’s crucial that patients and their families know about this new option," said Dr. William Russell, an oncology radiologist in Louisiana.

Wayne Hawkins believes terminally ill people should be able to die when they choose, but others in the state disagree.

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an initial public offering (IPO) on the week of April 7th, IPO Scoop reports. The company plans to issue 2,700,000 shares at $7.

With a plan to unveil the non-invasive prostate treatment on the horizon and a push for more robotic surgery training, ...

Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.

John Cena may be known for his unbreakable strength and larger-than-life persona, but even he isn’t immune to life’s most ...

Prostate cancer is one of the most common cancers that occur in men. While it can be life-threatening, the disease is ...

Katie Thurston revealed her true emotions during a chemo class, after revealing that her breast cancer progressed to stage 4.

Every year, the Iowa Cancer Registry releases a report looking at the projected top 10 cancers in Iowa between men and women.

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

A trial tested MRI and microultrasonography guided biopsy separately and in combination for the detection of clinically significant prostate cancer.

Here is a roundup of March 2025 U.S. FDA approvals across cancer subtypes, including prostate, bladder and gastrointestinal ...